Assadian Farzaneh, Nikbakht Gholamreza, Niazi Siavash, Khaltabadi Reza Farahani, Jahantigh Monireh
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran,
Vet Res Commun. 2014 Jun;38(2):157-63. doi: 10.1007/s11259-014-9599-9. Epub 2014 Mar 5.
The eukaryotic expression plasmid of M2e-Hsp70 is a candidate M2e-based DNA vaccine. In order to evaluate the immunization potential of this construct, Specific Pathogen Free chickens were immunized either intramuscularly or orally. Mutant Salmonella typhimurium was used as carrier for oral delivery of the M2e-Hsp70 construct. M2e-specific humoral and cellular responses were tested by ELISA and Lymphocyte Proliferation Assay, respectively. Our results indicate that both humoral and cellular immune responses are conferred against M2e-Hsp70 plasmid in either of the intramuscular or oral routes of administration; however, these responses are significantly higher in intramuscular injection in contrast to oral administration. When it comes to mass vaccination of commercial chicken flocks oral administration is preferred due to the ease of application as well as its capability of eliciting mucosal, humoral and cellular immune responses; so measurements should be taken to improve the immunization potency of our orally delivered DNA vaccine.
M2e-Hsp70真核表达质粒是一种基于M2e的候选DNA疫苗。为了评估该构建体的免疫潜力,对无特定病原体鸡进行了肌肉注射或口服免疫。突变型鼠伤寒沙门氏菌用作口服递送M2e-Hsp70构建体的载体。分别通过ELISA和淋巴细胞增殖试验检测M2e特异性体液和细胞反应。我们的结果表明,肌肉注射或口服途径均可诱导针对M2e-Hsp70质粒的体液和细胞免疫反应;然而,与口服给药相比,肌肉注射后的这些反应明显更高。对于商业鸡群的大规模疫苗接种,由于其易于应用以及能够引发粘膜、体液和细胞免疫反应,口服给药是首选;因此,应采取措施提高我们口服DNA疫苗的免疫效力。